Skip to content

Application of BCI combined with transcranial magnetic stimulation in rehabilitation of severe upper limb hemiplegia after stroke

Application of BCI combined with transcranial magnetic stimulation in rehabilitation of severe upper limb hemiplegia after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095965
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-02-16
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Normal control group:Routine rehabilitation training
sham rTMS combined with BCI group:On the basis of routine rehabilitation training, patients were given BCI rehabilitation training after sham rTMS intervention
low frequency rTMS combined with BCI group:On the basis of routine rehabilitation training, patients were given BCI rehabilitation training after low-frequency rTMS (1Hz) treatment intervention.
High-frequency rTMS combined with BCI group:On the basis of routine rehabilitation training, the patients received high-frequency rTMS (10Hz) treatment intervention and then received BCI rehabilitatio
BCI brain control mode of TMS group:On the basis of routine rehabilitation training, the patients underwent 30 minutes of BCI brain-controlled magnetic stimulation training.
BCI brain control mode of sham TMS group:On the basis of routine rehabilitation training, patients underwent 30 minutes of BCI brain-controlled sham magnetic stimulation stimulation.

Sponsors

The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Normal control group: Select age and gender matched normal individuals as the control group. 2. Patients’ group: (1) Meet the diagnostic criteria for stroke (cerebral hemorrhage and cerebral infarction) formulated by the fourth National Conference on Cerebrovascular Diseases; (2) Head CT and magnetic resonance examination confirmed the first onset, accompanied by complete upper limb motor dysfunction, the manifestations of NIHSS>7, SAFE0.15; (3) MRI and intracranial vascular examination confirmed that the focal site of stroke was the middle cerebral artery blood supply area; (4) Patients included in this study agreed to sign informed consent forms and related documents.

Exclusion criteria

Exclusion criteria: 1 Patients with limb dysfunction caused by other neurological diseases; 2 The lesion sites were non-middle cerebral artery blood supply areas such as brainstem and cerebellum; 3 There are serious cognitive disorders (MMSE<16 points), speech disorders, mental disorders and consciousness disorders, such as inability to cooperate; 4 Taking drugs that have an effect on cortical excitability or muscle activity (mainly including tricyclic antidepressants, benzodiazepines, muscle relaxants, nerve blockers and antiepileptic drugs); 5 Patients with progressive stroke or malignant progressive hypertension, serious visceral system diseases, etc.; 6 Patients with severe shoulder pain, shoulder-hand syndrome or shoulder dislocation; 7 Patients with contraindications to rTMS therapy such as epilepsy and metal implants.

Design outcomes

Primary

MeasureTime frame
Upper limb motor function index;Metabolomics indicators;

Secondary

MeasureTime frame
Neuroelectrophysiological index;Neuroimaging index;Near-infrared brain function imaging index;EEG index;

Countries

China

Contacts

Public ContactGong Yan

Suzhou Municipal Hospital

gongyan200605@126.com+86 188 6213 1396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026